CVE-2026-101451
Vulnerability in the Siebel Life Sciences product of Oracle Siebel CRM (component: Web UI).
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.32%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Vulnerability in the Siebel Life Sciences product of Oracle Siebel CRM (component: Web UI). Supported versions that are affected are 17.0-26.9. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Siebel Life Sciences. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Siebel Life Sciences, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Siebel Life Sciences accessible data as well as unauthorized access to critical data or complete access to all Siebel Life Sciences accessible data. CVSS 3.1 Base Score 8.7 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N).
- CVSS 3.1
- 8.7 HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N
- EPSS
- 0.32% probability · 25th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Source
- secalert_us@oracle.com
EPSS moved from 0.3% on 21 October 2026 to 0.3% on 26 October 2026.
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.